C646 caused suppression of MYC expression and apoptosis in CBP-deficient cancer types, specifically in CBP-mutant non-small cell lung cancer, T-ALL, and follicular B-cell lymphoma [160]. This evidence concerns the gene CREBBP and non-small cell lung carcinoma.